Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Hammer

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
The Journal of Infectious Diseases|January 1, 2003
Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapyCamlin Tierney, Janet L Lathey, Cindy Christopherson, et al.
The New England Journal of Medicine|October 28, 2014
Ebola and quarantineJeffrey M Drazen, Rupa Kanapathipillai, Edward W Campion, et al.
The Journal of Infectious Diseases|March 5, 2004
Detection of drug-resistant minority variants of HIV-1 during virologic failure of indinavir, lamivudine, and zidovudineCarrie Dykes, Joe Najjar, Ronald J Bosch, et al.
Journal of Medical Virology|June 25, 2009
The relationship between genotypic sensitivity score and treatment outcomes in late stage HIV disease after supervised HAARTDelivette Castor, David Vlahov, Donald R Hoover, et al.
Plos One|May 3, 2011
Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humansSamuel O Pine, James G Kublin, Scott M Hammer, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Indinavir, efavirenz, and abacavir pharmacokinetics in human immunodeficiency virus-infected subjectsRobert DiCenzo, Alan Forrest, Kathleen E Squires, et al.
Clinical Pharmacology and Therapeutics|August 22, 2002
Effect of coadministration of nelfinavir, indinavir, and saquinavir on the pharmacokinetics of amprenavirMarc Pfister, Line Labbé, Jian-Feng Lu, et al.
The Journal of Antimicrobial Chemotherapy|July 23, 2004
Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infectionsMagdalena E Sobieszczyk, E Yoko Furuya, Christine M Hay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388Lisa M Demeter, Heather J Ribaudo, Alejo Erice, et al.
International Journal of Health Geographics|July 25, 2009
Combining Google Earth and GIS mapping technologies in a dengue surveillance system for developing countriesAileen Y Chang, Maria E Parrales, Javier Jimenez, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|January 1, 2003
Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapyCamlin Tierney, Janet L Lathey, Cindy Christopherson, et al.
The New England Journal of Medicine|October 28, 2014
Ebola and quarantineJeffrey M Drazen, Rupa Kanapathipillai, Edward W Campion, et al.
The Journal of Infectious Diseases|March 5, 2004
Detection of drug-resistant minority variants of HIV-1 during virologic failure of indinavir, lamivudine, and zidovudineCarrie Dykes, Joe Najjar, Ronald J Bosch, et al.
Journal of Medical Virology|June 25, 2009
The relationship between genotypic sensitivity score and treatment outcomes in late stage HIV disease after supervised HAARTDelivette Castor, David Vlahov, Donald R Hoover, et al.
Plos One|May 3, 2011
Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humansSamuel O Pine, James G Kublin, Scott M Hammer, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Indinavir, efavirenz, and abacavir pharmacokinetics in human immunodeficiency virus-infected subjectsRobert DiCenzo, Alan Forrest, Kathleen E Squires, et al.
Clinical Pharmacology and Therapeutics|August 22, 2002
Effect of coadministration of nelfinavir, indinavir, and saquinavir on the pharmacokinetics of amprenavirMarc Pfister, Line Labbé, Jian-Feng Lu, et al.
The Journal of Antimicrobial Chemotherapy|July 23, 2004
Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infectionsMagdalena E Sobieszczyk, E Yoko Furuya, Christine M Hay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388Lisa M Demeter, Heather J Ribaudo, Alejo Erice, et al.
International Journal of Health Geographics|July 25, 2009
Combining Google Earth and GIS mapping technologies in a dengue surveillance system for developing countriesAileen Y Chang, Maria E Parrales, Javier Jimenez, et al.
Pageof 9